NRX Pharmaceuticals (NRXP) Net Equity Issued and Repurchased (2017 - 2026)

NRX Pharmaceuticals (NRXP) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $3.4 million in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 64.14% decrease from a year earlier, with the FY2025 full-year figure at $6.4 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $3.4 million, up from $1.6 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for NRXP reached as high as $3.7 million in Q3 2025 and fell as low as $1.0 million in Q2 2025.